Publication | Closed Access

Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines

Anti-cancer AgentsZoledronic AcidOncologyPharmacologyThird-generation BisphosphonateBronchial NeoplasmAnti-cancer AgentCancer TreatmentMedicineLung Cancer